American International Group, Inc. Atara Biotherapeutics, Inc. Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$0.44 - $1.22 $180 - $500	-410 Reduced 0.85%	47,731 $32,000
Q4 2023 Feb 13, 2024	SELL	$0.23 - $1.74 $44 - $337	-194 Reduced 0.4%	48,141 $24,000
Q3 2023 Nov 13, 2023	BUY	$1.41 - $2.31 $3,324 - $5,446	2,358 Added 5.13%	48,335 $71,000
Q2 2023 Aug 04, 2023	BUY	$1.5 - $3.04 $721 - $1,462	481 Added 1.06%	45,977 $74,000
Q1 2023 May 12, 2023	BUY	$2.8 - $5.46 $4,569 - $8,910	1,632 Added 3.72%	45,496 $131,000
Q4 2022 Feb 10, 2023	SELL	$2.85 - $5.18 $456 - $828	-160 Reduced 0.36%	43,864 $143,000
Q3 2022 Nov 14, 2022	BUY	$2.85 - $8.73 $3,026 - $9,271	1,062 Added 2.47%	44,024 $166,000
Q2 2022 Aug 12, 2022	SELL	$4.69 - $9.84 $872 - $1,830	-186 Reduced 0.43%	42,962 $335,000
Q1 2022 May 13, 2022	SELL	$8.44 - $16.89 $25,640 - $51,311	-3,038 Reduced 6.58%	43,148 $401,000
Q4 2021 Feb 11, 2022	BUY	$14.7 - $19.89 $14,009 - $18,955	953 Added 2.11%	46,186 $728,000
Q3 2021 Nov 12, 2021	SELL	$11.99 - $17.9 $12,877 - $19,224	-1,074 Reduced 2.32%	45,233 $810,000
Q2 2021 Aug 13, 2021	SELL	$12.89 - $16.58 $5,478 - $7,046	-425 Reduced 0.91%	46,307 $720,000
Q1 2021 May 07, 2021	BUY	$14.0 - $20.72 $38,262 - $56,627	2,733 Added 6.21%	46,732 $671,000
Q4 2020 Feb 12, 2021	BUY	$12.67 - $26.23 $9,122 - $18,885	720 Added 1.66%	43,999 $864,000
Q3 2020 Nov 04, 2020	BUY	$11.92 - $15.87 $97,314 - $129,562	8,164 Added 23.25%	43,279 $561,000
Q2 2020 Aug 12, 2020	BUY	$7.53 - $14.93 $34,916 - $69,230	4,637 Added 15.21%	35,115 $512,000
Q1 2020 May 04, 2020	SELL	$5.69 - $17.78 $10,025 - $31,328	-1,762 Reduced 5.47%	30,478 $259,000
Q4 2019 Feb 05, 2020	SELL	$10.89 - $16.79 $2,951 - $4,550	-271 Reduced 0.83%	32,240 $531,000
Q3 2019 Nov 08, 2019	BUY	$12.03 - $19.94 $51,753 - $85,781	4,302 Added 15.25%	32,511 $459,000
Q2 2019 Aug 13, 2019	BUY	$19.05 - $41.04 $27,813 - $59,918	1,460 Added 5.46%	28,209 $567,000
Q1 2019 May 06, 2019	SELL	$28.4 - $41.74 $24,622 - $36,188	-867 Reduced 3.14%	26,749 $1.06 Million
Q4 2018 Feb 13, 2019	SELL	$30.9 - $42.97 $6,550 - $9,109	-212 Reduced 0.76%	27,616 $959,000
Q3 2018 Nov 09, 2018	BUY	$35.05 - $43.5 $47,037 - $58,377	1,342 Added 5.07%	27,828 $1.15 Million
Q2 2018 Aug 08, 2018	BUY	$35.15 - $51.45 $191,672 - $280,556	5,453 Added 25.93%	26,486 $973,000
Q1 2018 May 07, 2018	BUY	$18.0 - $48.35 $54,306 - $145,871	3,017 Added 16.75%	21,033 $820,000
Q4 2017 Feb 09, 2018	BUY	$13.2 - $18.1 $12,355 - $16,941	936 Added 5.48%	18,016 $326,000
Q3 2017 Nov 09, 2017	BUY	$13.25 - $17.05 $226,310 - $291,214	17,080	17,080 $283,000

Others Institutions Holding ATRA

# of Institutions

Shares Held

2.89M

Call Options Held

Put Options Held

View Full List

About Atara Biotherapeutics, Inc.

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.08B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

More about ATRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account